These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25391644)

  • 1. Concise review: engineering the fusion of cytokines for the modulation of immune cellular responses in cancer and autoimmune disorders.
    Ng S; Galipeau J
    Stem Cells Transl Med; 2015 Jan; 4(1):66-73. PubMed ID: 25391644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GMCSF-interleukin fusion cytokines induce novel immune effectors that can serve as biopharmaceuticals for treatment of autoimmunity and cancer.
    Williams P; Galipeau J
    J Intern Med; 2011 Jan; 269(1):74-84. PubMed ID: 21158980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF-based fusion cytokines as ligands for immune modulation.
    Williams P; Galipeau J
    J Immunol; 2011 May; 186(10):5527-32. PubMed ID: 21540457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
    Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
    J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-cytokine fusion proteins for the therapy of cancer.
    Penichet ML; Morrison SL
    J Immunol Methods; 2001 Feb; 248(1-2):91-101. PubMed ID: 11223071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction, expression, and characterization of anticarcinoma sFv fused to IL-2 or GM-CSF.
    Zhao L; Rai SK; Grosmaire LS; Ledbetter JA; Fell HP
    J Hematother Stem Cell Res; 1999 Aug; 8(4):393-9. PubMed ID: 10634177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer.
    Gillies SD; Lan Y; Brunkhorst B; Wong WK; Li Y; Lo KM
    Cancer Immunol Immunother; 2002 Oct; 51(8):449-60. PubMed ID: 12202906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell-cell interactions.
    Wen Q; Xiong W; He J; Zhang S; Du X; Liu S; Wang J; Zhou M; Ma L
    J Transl Med; 2016 Feb; 14():41. PubMed ID: 26850448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF.
    Hu Z; Tan W; Zhang L; Liang Z; Xu C; Su H; Lu J; Gao J
    J Cell Mol Med; 2010 Jun; 14(6B):1836-44. PubMed ID: 19627402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis.
    Seymour JF; Begley CG; Dirksen U; Presneill JJ; Nicola NA; Moore PE; Schoch OD; van Asperen P; Roth B; Burdach S; Dunn AR
    Blood; 1998 Oct; 92(8):2657-67. PubMed ID: 9763547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.
    Kumar A; Taghi Khani A; Sanchez Ortiz A; Swaminathan S
    Front Immunol; 2022; 13():901277. PubMed ID: 35865534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia cells in G0 phase of the cell cycle that are unresponsive to conventional chemotherapy are sensitive to treatment with granulocyte-macrophage colony-stimulating factor/diphtheria toxin fusion proteins.
    Jedema I; Barge RM; Frankel AE; Willemze R; Falkenburg JH
    Exp Hematol; 2004 Feb; 32(2):188-94. PubMed ID: 15102480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-cytokine fusion proteins for the therapy of cancer.
    Helguera G; Penichet ML
    Methods Mol Med; 2005; 109():347-74. PubMed ID: 15585931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of B cells into regulatory cells with engineered fusokines.
    Deng J; Galipeau J
    Infect Disord Drug Targets; 2012 Jun; 12(3):248-54. PubMed ID: 22394176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
    Bhattacharya P; Budnick I; Singh M; Thiruppathi M; Alharshawi K; Elshabrawy H; Holterman MJ; Prabhakar BS
    J Interferon Cytokine Res; 2015 Aug; 35(8):585-99. PubMed ID: 25803788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development.
    Vadhan-Raj S
    Stem Cells; 1994 May; 12(3):253-61. PubMed ID: 8075592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease.
    Heinzelman P; Priebe MC
    Biotechnol Prog; 2015; 31(3):668-77. PubMed ID: 25737095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.